Synthesis of hypolipidemic silybin analog 3',4'-ethylenedioxyflavonoids. 1984

G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev

For pharmacological investigation various types of silybin analogues have been synthesized. According to the results of preliminary tests, many of the prepared benzodioxane analogues of chalcones, chalcone epoxides, isoflavones, flavanones and aurones possessed hypolipidemic activity.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D012838 Silymarin A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent. Carsil,Karsil,Legalon,Silimarin
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
April 1974, The American journal of pathology,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
November 1988, Chemical & pharmaceutical bulletin,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
March 1986, Journal of medicinal chemistry,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
February 1987, Pharmaceutical research,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
June 1985, Chemical & pharmaceutical bulletin,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
April 1985, Chemical & pharmaceutical bulletin,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
March 1996, Journal of medicinal chemistry,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
May 1989, Chemical & pharmaceutical bulletin,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
March 1969, Journal of pharmaceutical sciences,
G Y Litkei, and T Patonay, and R Bognár, and V Khilja, and A Aitmambetov, and A Turov, and F Babichev
September 1983, The Journal of antibiotics,
Copied contents to your clipboard!